Senseonics Shares Rise 19% After Anthem Provides Coverage for Implantable CGM

Dow Jones2022-08-03
 

By Chris Wack

 

Senseonics Holdings Inc. shares were up 19% to $1.51 Wednesday after the company said that health insurer Anthem is providing coverage for implantable continuous glucose monitoring, which includes the Eversense CGM System.

The company said Anthem's decision will add more than 45 million covered lives for the long-term implantable CGM system to help manage their diabetes.

This allows Ascensia Diabetes Care, Senseonics' global commercial partner, to introduce the Eversense CGM System to more people living with diabetes.

Through its affiliated companies, Anthem, now Elevance Health Inc., serves people across 14 states, including more than 45 million within its family of health plans.

The stock hit its 52-week low of 77 cents on May 12.

 

Write to Chris Wack at chris.wack@wsj.com

 

$(END)$ Dow Jones Newswires

August 03, 2022 10:30 ET (14:30 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • AddyYamada
    2022-08-04
    AddyYamada
    Time to release the tigers
  • yngwin111
    2022-08-04
    yngwin111
    Good news 
Leave a comment
2